During the past decade, New England Research Associates, Llc conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 45 clinical trials were completed, i.e. on average, 160.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 26 clinical trials were completed. i.e. 236.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New England Research Associates, Llc" #1 sponsor was "Pfizer" with 23 trials, followed by "Eli Lilly and Company" with 10 trials sponsored, "Bristol-Myers Squibb" with 7 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "CSL Behring" with 3 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New England Research Associates, Llc" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "New England Research Associates, Llc" are "Rheumatoid Arthritis" (14 trials), "Coronary Artery Disease" (6 trials), "Psoriasis" (5 trials), "Low Back Pain" (4 trials) and "Psoriatic Arthritis" (4 trials). Many other conditions were trialed in "New England Research Associates, Llc" in a lesser frequency.

Most popular intervention types in "New England Research Associates, Llc" are "Drug" (62 trials), "Biological" (12 trials), "Other" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Baricitinib" (5 trials), "Methotrexate" (5 trials), "Abatacept" (4 trials) and "Adalimumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "New England Research Associates, Llc" are 73 trials for "All" genders.

Currently, there are NaN active trials in "New England Research Associates, Llc". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in New England Research Associates, Llc, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in New England Research Associates, Llc, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".